Renal Cell Carcinoma

Molecular Targets and Clinical Applications, Second Edition

Editors: Bukowski, Ronald, Figlin, Robert A., Motzer, Robert (Eds.)

Free Preview
  • Explores the development and use of angiogenesis and tyrosine kinase inhibitors in epithelial renal tumor treatment
  • Presents the latest findings in the field of molecular medicine and the exploration of novel targets as therapies for renal cell carcinomas
  • Provides substantive background on the research data and clinical findings of the latest gene therapy studies
see more benefits

Buy this book

eBook $149.00
price for USA in USD (gross)
  • ISBN 978-1-59745-332-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
About this book

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

Reviews

From the reviews of the second edition:

"Chapters in this book are written by an authoritative group of contributors who are well known for their translational and clinical work in kidney cancer. … The primary audience includes individuals on the cusp of translational … in kidney cancer. … for most practicing medical oncologists, the book provides essential data upon which their daily clinical decisions are based when caring for patients afflicted with kidney cancer. … The strength of this book lies in … its sharp insights into a rapidly evolving field." (Robert G Uzzo, Doody’s Review Service, June, 2009)


Table of contents (25 chapters)

Table of contents (25 chapters)
  • Targeted Therapy for Metastatic Renal Cell Carcinoma: Overview

    Bukowski, Ronald M. (et al.)

    Pages 1-12

  • Molecular Genetics in Inherited Renal Cell Carcinoma: Identification of Targets in the Hereditary Syndromes

    Dhanani, Nadeem (et al.)

    Pages 13-33

  • Molecular Targets in Renal Tumors: Pathologic Assessment

    Zhou, M.

    Pages 35-48

  • Interferons and Interleukin-2: Molecular Basis of Activity and Therapeutic Results

    Hutson, Thomas E. (et al.)

    Pages 49-78

  • The Molecular Biology of Kidney Cancer and Its Clinical Translation into Treatment Strategies

    Kaelin Jr., William G. (et al.)

    Pages 79-97

Buy this book

eBook $149.00
price for USA in USD (gross)
  • ISBN 978-1-59745-332-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Renal Cell Carcinoma
Book Subtitle
Molecular Targets and Clinical Applications, Second Edition
Editors
  • Ronald Bukowski
  • Robert A. Figlin
  • Robert Motzer
Copyright
2009
Publisher
Humana Press
Copyright Holder
Humana Press
eBook ISBN
978-1-59745-332-5
DOI
10.1007/978-1-59745-332-5
Edition Number
2
Number of Pages
XVIII, 506
Number of Illustrations
25 illustrations in colour
Topics